The use of angiotensin-converting enzyme inhibitors but not angiotensin receptor blockers in hospitalized patients with COVID-19 is associated with a lower risk of mortality
Khalangot, M.; Gurianov, V.; Zakharchenko, T.; Kravchenko, V.; Kovzun, O.; Shupachynskiy, V.; Tronko, M.
Show abstract
The relationship between the use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs), diabetes mellitus (DM), and the risk of death in patients with COVID-19 remains controversial. We hypothesized that DM and certain characteristics of the COVID-19 course during hospital treatment may alter the assessment of the effect of ACEIs/ARBs on COVID-19 outcomes. The records of 153 COVID-19 inpatients admitted to a municipal clinic in Kyiv, Ukraine, between October and December 2021 were reviewed. To assess the effect of ARBs/ACEIs and other hypotensive drugs, a no hypotensives group was used for comparison. A multivariable logistic regression model was employed to assess the odds ratio (OR) of death. If DM was known at the time of hospitalization (n=28), there was a higher proportion of deaths compared to the group without DM (n=125): 53.6% vs. 12.8%, p < 0.001. After adjusting for age, minimal O2 saturation, DM, and antihypertensive therapy, the ACEIs-associated OR was 0.10 (0.02-0.69). The DM-associated OR was 8.25 (1.92-35.42). The use of ACEIs in the treatment of COVID-19 inpatients is associated with a lower risk of mortality compared to those not using hypotensive treatment, regardless of the presence of DM.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Prevalence and determinants of peripheral arterial disease in children with nephrotic syndrome 95%
- Assessing Red Blood Cell Distribution Width in Vietnamese Heart Failure Patients: A Cross-Sectional Study 95%
- Prevalence of cardiometabolic risk factors according to urbanization level, gender and age, in apparently healthy adults living in Gabon, Central Africa 95%
Similar papers in this journal
- Early Outpatient Treatment Of COVID-19: A Retrospective Analysis Of 392 Cases In Italy 95%
- Efficacy of remdesivir-containing therapy in hospitalized COVID-19 patients: a prospective clinical experience 94%
- Administration of tocilizumab to patients with high concentrations of IL-6 in the course of COVID-19 is associated with a better prognosis 94%
Similar papers in this journal
- Association of non-HDL-C/apoB ratio with long-term mortality in the general population: a cohort study 94%
- Influence of body mass index on SAPS3 prognostic performance in critically ill patients from Brazil 92%
- Effect of xenon and argon inhalation on erythropoiesis and steroidogenesis: a systematic review 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.